| 000 | 01403 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516060909.0 | ||
| 264 | 0 | _c20120228 | |
| 008 | 201202s 0 0 eng d | ||
| 022 | _a1471-2369 | ||
| 024 | 7 |
_a10.1186/1471-2369-12-55 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPepper, Ruth | |
| 245 | 0 | 0 |
_aDo oral aluminium phosphate binders cause accumulation of aluminium to toxic levels? _h[electronic resource] |
| 260 |
_bBMC nephrology _cOct 2011 |
||
| 300 |
_a55 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aAluminum _xblood |
| 650 | 0 | 4 |
_aAluminum Compounds _xblood |
| 650 | 0 | 4 | _aDeferoxamine |
| 650 | 0 | 4 |
_aDialysis Solutions _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperphosphatemia _xblood |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xcomplications |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOsmosis |
| 650 | 0 | 4 |
_aPhosphates _xblood |
| 650 | 0 | 4 | _aRenal Dialysis |
| 650 | 0 | 4 |
_aRisk Assessment _xmethods |
| 650 | 0 | 4 | _aSiderophores |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aCampbell, Neil | |
| 700 | 1 | _aYaqoob, Magdi M | |
| 700 | 1 | _aRoberts, Norman B | |
| 700 | 1 | _aFan, Stanley L-S | |
| 773 | 0 |
_tBMC nephrology _gvol. 12 _gp. 55 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1471-2369-12-55 _zAvailable from publisher's website |
| 999 |
_c21225813 _d21225813 |
||